Literature DB >> 3705686

[Surgical therapy of intracardiac infected pacemaker electrodes and catheter remnants].

S Schüler, R Hetzer, T Stegmann, H G Borst.   

Abstract

With the increase of pacemaker and central venous catheter implantation the number of intracardiac infections now constitutes a significant problem. Twenty patients between 22 and 77 years of age admitted for intracardial infected pacemaker probes or central venous catheter remnants presented with recurring attacks of endocarditic fever; in one case multiple pulmonary abscesses resulted from septic embolization. Staphylococci were the most frequently involved organism (75%). Risk factors leading to intracardiac infection were local reoperations and diabetes mellitus. Removal of the foreign body was achieved by cardiotomy in all cases. Twelve patients were operated upon without the use of the heart-lung machine, but extracorporeal circulation was necessary in 8 patients. There was one fatality in each of the 2 techniques, for a total mortality rate of 10%. In all cases the foreign bodies were removed without intracardial damage and the endocarditis was cured. When attempts at external extraction fail, the foreign body should be removed by either open or closed cardiotomy. This limits the danger of injury to the heart and of embolization of septic or thrombotic material. The use of the heart-lung machine is especially indicated in the presence of widespread, firm adhesions, or large bacterial vegetations and thrombi.

Entities:  

Mesh:

Year:  1986        PMID: 3705686

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  1 in total

1.  Percutaneous retrieval of centrally embolized fragments of central venous access devices or knotted Swan-Ganz catheters. Clinical report of 14 retrievals with detailed angiographic analysis and review of procedural aspects.

Authors:  Łukasz Kalińczuk; Zbigniew Chmielak; Artur Dębski; Cezary Kępka; Piotr N Rudziński; Sebastian Bujak; Mirosław Skwarek; Andrzej Kurowski; Zofia Dzielińska; Marcin Demkow
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-05-11       Impact factor: 1.426

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.